AVH 2.02% $2.42 avita medical inc.

new uk recell burns trial begining in july, page-2

  1. 10,009 Posts.
    Interesting to read, it appears, they are trialling the RECELL to see if it performs better than the SKIN SHEETS.

    If all goes well RECELL could become the standard of care in the UK.

    Also of note is the biopsys to see which cells are most active. Am I correct in thinking RECELL 3 differant cells as opposed to the Skin sheet having just one.

    And RECELL has other magic , not yet identified or understood entirely?.

    Hope the company makes some comment so we can hear from the experts .
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.42
Change
-0.050(2.02%)
Mkt cap ! $161.1M
Open High Low Value Volume
$2.43 $2.44 $2.38 $737.5K 305.9K

Buyers (Bids)

No. Vol. Price($)
4 4807 $2.42
 

Sellers (Offers)

Price($) Vol. No.
$2.43 171 2
View Market Depth
Last trade - 15.35pm 26/06/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.